Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Senthilkumar, Rajasekaran"'
Autor:
Karthi, Muthuswamy, Deepankumar, Shanmugamprema, Vinithra, Ponnusamy, Gowtham, Subramanian, Vasanth, Krishnan, Praveen Raj, Palanivelu, Senthilkumar, Rajasekaran, Selvakumar, Subramaniam
Publikováno v:
In Clinical Nutrition May 2021 40(5):2707-2715
Autor:
SenthilKumar Rajasekaran, AnilChankaramangalam Mathew, Benson Benny, Debin Sunny, Srigowtham Subramaniam
Publikováno v:
Indian Journal of Health Sciences and Biomedical Research (KLEU). 15:121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1246fbb7f41adebf4e7d262811a1c991
https://doi.org/10.4103/kleuhsj.kleuhsj_266_21
https://doi.org/10.4103/kleuhsj.kleuhsj_266_21
Autor:
Senthilkumar Rajasekaran, Arun M Ram
Publikováno v:
The FASEB Journal. 33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a1b2a6d67b0953ee013f3b8849fc5b7
https://doi.org/10.1096/fasebj.2019.33.1_supplement.803.9
https://doi.org/10.1096/fasebj.2019.33.1_supplement.803.9
Publikováno v:
Indian Journal of Science and Technology. 8
Objectives: A weakness in software development is providing security against piracy. The objective of the paper is to provide the security using the k-DRM which will reduce the rate of piracy. Methods: Advanced Rights Management (DRM) frameworks atte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49ddf2c2c4bfa8699e1e4c8611952d96
https://doi.org/10.17485/ijst/2015/v8i17/67408
https://doi.org/10.17485/ijst/2015/v8i17/67408
Publikováno v:
Journal of Clinical and Experimental Hepatology. 4:66-67
Jaundice in Grave's diseases is uncommon, but when it does occur, complication of thyrotoxicosis (heart failure/infection) or intrinsic liver disease should be considered. Grave's disease can cause asymptomatic elevation of liver enzymes, jaundice an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::178d62b05670acb2f8bdd83618bbca81
https://doi.org/10.1016/j.jceh.2013.08.001
https://doi.org/10.1016/j.jceh.2013.08.001
Publikováno v:
Journal of Clinical and Experimental Hepatology. 2:86-87
A 16-year-old female was treated with pegylated-interferon (PEG-IFN) alfa (a)-2b and ribavirin combination therapy for chronic hepatitis C virus (HCV) infection. She attained rapid virological response. She presented with diabetic ketoacidosis after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82998ef6d4581c456b1f87ed68ddb064
https://doi.org/10.1016/s0973-6883(12)60089-9
https://doi.org/10.1016/s0973-6883(12)60089-9